Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes (Q58448492)
Jump to navigation
Jump to search
article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes |
article |
Statements
Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes (English)
Arthur Bergman
Catherine Stevens
Paul Kotey
Bingming Yi
Peng Zhao
Bruno Dietrich
George Golor
Andreas Schrodter
Bart Keymeulen
Karen Snyder
Deborah Hilliard
Michael Tanen
Caroline Cilissen
Marina De Smet
Inge de Lepeleire
Kristien Van Dyck
Wei Zeng
Wesley Tanaka
Gary A Herman
Kenneth C Lasseter
Mark S Kipnes
Amy Q Wang
Michael J Davies
Keith M Gottesdiener
John A Wagner
15 August 2006